Why is Aristo Bio-Tech falling/rising?

As of 13-Jun, Aristo Bio-Tech & Lifescience Ltd's stock price is currently at 113.50, reflecting a decline of 4.5 points or 3.81%. The stock has underperformed its sector by 4.32% today and is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Over the past week, the stock has decreased by 8.21%, and it has seen a year-to-date decline of 14.66%, contrasting with a 4.54% increase in the benchmark Sensex. Although there has been a rise in investor participation, with delivery volume increasing by 25% against the 5-day average, there are no positive or negative factors available to further explain the stock's recent movement.
Broader Market Context: In the short term, Aristo Bio-Tech's performance has significantly lagged behind the Sensex, which has only declined by 1.14% over the past week. This stark contrast highlights the stock's struggles relative to the broader market, as it has not only underperformed in the short term but also shows a negative trend year-to-date compared to the benchmark's positive performance. The liquidity of the stock remains adequate for trading, but the overall negative momentum suggests that investor sentiment may be cautious.